MiniMed, a global leader in diabetes technology, has announced the commercial launch in Europe of both the MiniMed 780G system integrated with the Instinct sensor and the MiniMed Go system integrated with the Instinct Go sensor. The Instinct and Instinct Go sensors, made by Abbott, will be rolled out gradually across Europe starting this month, expanding MiniMed’s sensor portfolio in the region.
“People with diabetes should not have to choose between flexibility and performance when managing their diabetes, and with MiniMed, they don’t have to,” said Que Dallara, CEO, MiniMed. “Expanding our sensor portfolio across Europe with Instinct and Instinct Go means more people can access the proven outcomes, intelligent insights, and seamless automation MiniMed is known for. This is about meeting people where they are and building technology that fits their life — not the other way around. That’s what drives us every day.”
For people with type 1 diabetes, accurately counting carbs and remembering to take insulin up to 15 minutes before meals can be challenging, often leading to post-meal blood glucose spikes when doses are delayed, missed, or underestimated.
MiniMed says the MiniMed 780G system is the only system with Meal Detection technology designed to reduce post-meal blood glucose spikes when users occasionally forget to bolus or underestimate carbs. Paired with the 15-day Instinct sensor, the MiniMed 780G system offers greater choice and flexibility while maintaining proven clinical performance according to the company.
Recent data from a new randomised crossover study, published in Diabetes Technology & Therapeutics, demonstrated glycemic outcomes were virtually identical when using the MiniMed 780G system with either the Simplera Sync sensor or Instinct sensor. MiniMed says these results were reinforced by a real-world analysis of over 20,000 U.S. users of the MiniMed 780G system.
For people using multiple daily injections (MDI), diabetes management remains fragmented across disconnected tools, creating constant “mental math” in daily life. The MiniMed Go system integrated with the Instinct Go sensor brings it all together in one place says the company.
The solution combines dose tracking with the InPen smart insulin pen and real-time CGM data, addressing the therapy adherence gap for MDI users by providing real-time alerts and actionable insights on a single mobile app when doses are missed or blood glucose spikes, helping MDI users stay on top of their diabetes with less effort.
The Instinct and Instinct Go sensors begin rolling out across European markets this month following CE mark approval earlier this year for integration with the two systems.
